Wanyuan Xiong
Overview
Explore the profile of Wanyuan Xiong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
1
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiong W, Li J, Mao X, Qian Z, Tian A, Peng X, et al.
Eur J Pharmacol
. 2025 Feb;
992:177352.
PMID: 39923824
Immune-mediated liver injury (ILI) is a condition characterized by inflammation and cell death in the liver. Disulfiram, an FDA-approved drug for alcohol aversion, shows potential as a therapeutic agent in...
2.
Xiong W, Tian A, Qian Z, Li J, Mao X
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Dec;
PMID: 39680099
Disulfiram, a synthetic drug, has historically played a significant role in the treatment of alcoholic liver disease as the first medication approved by the U.S. Food and Drug Administration for...
3.
Qian Z, Xiong W, Mao X, Li J
Biomolecules
. 2024 Jun;
14(6).
PMID: 38927103
Macrophages, as important immune cells of the organism, are involved in maintaining intrahepatic microenvironmental homeostasis and can undergo rapid phenotypic changes in the injured or recovering liver. In recent years,...
4.
Xiong W, Qian Z, Mao X, Li J
Clin Res Hepatol Gastroenterol
. 2022 Dec;
47(2):102070.
PMID: 36539180
T lymphocyte-mediated pyroptosis plays an important role in the development of non-viral liver diseases. Pyroptosis as a programmed cell death process, has been a hot topic of research on disease...